Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 40

Results For "China"

501 News Found

WHO report highlights the role of traditional Chinese medicine in the treatment of Covid-19
News | April 19, 2022

WHO report highlights the role of traditional Chinese medicine in the treatment of Covid-19

The report pointed out that in the process of treating Covid-19, there are promising data to suggest that TCM is beneficial in reducing the risk of progression from mild-to-moderate cases to severe Covid-19


SonoScape receives USFDA 510(k) clearance for HD-550 Endoscopy system
Drug Approval | April 18, 2022

SonoScape receives USFDA 510(k) clearance for HD-550 Endoscopy system

The HD-550 endoscopy system has been available outside of the USA since 2019


Henlius' Serplulimab granted Orphan-Drug Designation for Small Cell Lung Cancer
Biotech | April 08, 2022

Henlius' Serplulimab granted Orphan-Drug Designation for Small Cell Lung Cancer

The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC


Indian pharma growth likely to moderate in FY23: ICRA
News | April 07, 2022

Indian pharma growth likely to moderate in FY23: ICRA

Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23


Researchers discover new model for
Biotech | March 31, 2022

Researchers discover new model for "Global" DNA repair

A major unresolved question in the field, however, is how do this machinery rapidly searches for and finds rare stretches of damage amid the "vast fields" of undamaged DNA


GenScript wins Best CDMO award for the third time
News | March 30, 2022

GenScript wins Best CDMO award for the third time

The award also follows GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the "Best Contract Development and Manufacturing Organization Award".


New spesolimab data show promising results in patients with generalised pustular psoriasis flares
Biotech | March 28, 2022

New spesolimab data show promising results in patients with generalised pustular psoriasis flares

Clinical improvements were consistent across patient subgroups including age, gender, ethnicity, and IL-36 gene mutation status


NMPA approves Hansizhuang, its first monoclonal antibody
Drug Approval | March 27, 2022

NMPA approves Hansizhuang, its first monoclonal antibody

It also empowers domestic precision immunotherapy for tumours and promotes the high-quality development of China's biopharmaceutical industry


Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre
interviews | March 22, 2022

Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre

Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025


Thermo Fisher Scientific to showcase global innovation at DCAT Week 2022
Medical Device | March 22, 2022

Thermo Fisher Scientific to showcase global innovation at DCAT Week 2022

Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers